| Expression of cyclin D1 and EMS1 in bladder tumours; relationship with chromosome 11q13 amplification. PP Bringuier, Y Tamimi, E Schuuring, J Schalken Oncogene 12 (8), 1747-1753, 1996 | 202 | 1996 |
| Increased Expression of High Mobility Group Protein I(Y) in High Grade Prostatic Cancer Determined by in Situ Hybridization Y Tamimi, HG van der Poel, MM Denyn, R Umbas, HFM Karthaus, ... Cancer research 53 (22), 5512-5516, 1993 | 168 | 1993 |
| Expression of glucose transporter 1 (Glut-1) in cell lines and clinical specimens from human prostate adenocarcinoma P Effert, AJ Beniers, Y Tamimi, S Handt, G Jakse Anticancer research 24 (5A), 3057-3064, 2004 | 127 | 2004 |
| A retrospective study of high mobility group protein I (Y) as progression marker for prostate cancer determined by in situ hybridization Y Tamimi, HG van der Poel, HFM Karthaus, FM Debruyne, JA Schalken British journal of cancer 74 (4), 573-578, 1996 | 82 | 1996 |
| The establishment of a predictive mutational model of the forkhead domain through the analyses of FOXC2 missense mutations identified in patients … FB Berry, Y Tamimi, MV Carle, OJ Lehmann, MA Walter Human molecular genetics 14 (18), 2619-2627, 2005 | 71 | 2005 |
| Selective reovirus killing of bladder cancer in a co-culture spheroid model RT Kilani, Y Tamimi, EG Hanel, KK Wong, S Karmali, PWK Lee, RB Moore Virus research 93 (1), 1-12, 2003 | 60 | 2003 |
| p16 mutations/deletions are not frequent events in prostate cancer Y Tamimi, PP Bringuier, F Smit, A Van Bokhoven, FMJ Debruyne, ... British journal of cancer 74 (1), 120-122, 1996 | 59 | 1996 |
| FGF19 is a target for FOXC1 regulation in ciliary body-derived cells Y Tamimi, JM Skarie, T Footz, FB Berry, BA Link, MA Walter Human molecular genetics 15 (21), 3229-3240, 2006 | 54 | 2006 |
| Selective cytotoxicity of gemcitabine in bladder cancer cell lines RT Kilani, Y Tamimi, S Karmali, J Mackey, EG Hanel, KK Wong, RB Moore Anti-cancer drugs 13 (6), 557-566, 2002 | 54 | 2002 |
| Homozygous deletions of p16INK4 occur frequently in bilharziasis‐associated bladder cancer Y Tamimi, PP Bringuier, F Smit, A van Bokhoven, A Abbas, FMJ Debruyne, ... International journal of cancer 68 (2), 183-187, 1996 | 41 | 1996 |
| Identification of target genes regulated by FOXC1 using nickel agarose–based chromatin enrichment Y Tamimi, M Lines, M Coca-Prados, MA Walter Investigative ophthalmology & visual science 45 (11), 3904-3913, 2004 | 40 | 2004 |
| WNT5A is regulated by PAX2 and may be involved in blastemal predominant Wilms tumorigenesis Y Tamimi, U Ekuere, N Laughton, P Grundy Neoplasia 10 (12), 1470-1480, 2008 | 39 | 2008 |
| BRIP1 overexpression is correlated with clinical features and survival outcome of luminal breast cancer subtypes I Gupta, A Ouhtit, A Al-Ajmi, SGA Rizvi, H Al-Riyami, M Al-Riyami, ... Endocrine connections 7 (1), 65-77, 2018 | 31 | 2018 |
| Interstitial photodynamic therapy in subcutaneously implanted urologic tumors in rats after intravenous administration of 5-aminolevulinic acid Z Xiao, Y Tamimi, K Brown, J Tulip, R Moore Urologic Oncology: Seminars and Original Investigations 7 (3), 125-132, 2002 | 26 | 2002 |
| FAT4 silencing promotes epithelial-to-mesenchymal transition and invasion via regulation of YAP and β-catenin activity in ovarian cancer SH Malgundkar, I Burney, M Al Moundhri, M Al Kalbani, R Lakhtakia, ... BMC cancer 20, 1-11, 2020 | 23 | 2020 |
| Hoxb13, a potential prognostic biomarker for prostate cancer A Ouhtit, MN Al-Kindi, PR Kumar, I Gupta, S Shanmuganathan, Y Tamimi Front Biosci (Elite Ed) 8 (1), 40-45, 2016 | 23 | 2016 |
| Leiomyosarcoma of the bladder in a retinoblastoma patient SL Bléoo, R Godbout, D Rayner, Y Tamimi, RB Moore Urologia internationalis 71 (1), 118-121, 2003 | 23 | 2003 |
| Screening for anti-cancer compounds in marine organisms in Oman S Dobretsov, Y Tamimi, MA Al-Kindi, I Burney Sultan Qaboos University Medical Journal 16 (2), e168, 2016 | 19 | 2016 |
| DiagnoGene PCA3 reliable NASBA based reagents for detecting PCA3 niRNA, a recently described prostate marker Y Tamimi Proc. Am. Assoc. Cancer Res 39, 234, 0 | 19 | |
| Molecular genetics complexity impeding research progress in breast and ovarian cancers I Gupta, I Burney, MS Al‑Moundhri, Y Tamimi Molecular and clinical oncology 7 (1), 3-14, 2017 | 17 | 2017 |
Jack SchalkenHoogleraar experimentele urologieVerified email at radboudumc.nl
